ORGS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.52 -- higher than only 6.33% of US-listed equities with positive expected earnings growth.
With a year-over-year growth in debt of -41.92%, Orgenesis Inc's debt growth rate surpasses only 7.43% of about US stocks.
As for revenue growth, note that ORGS's revenue has grown -48.14% over the past 12 months; that beats the revenue growth of merely 5.53% of US companies in our set.
Stocks with similar financial metrics, market capitalization, and price volatility to Orgenesis Inc are AMBA, CVM, WATT, IPHI, and CUE.
ORGS's SEC filings can be seen here. And to visit Orgenesis Inc's official web site, go to www.orgenesis.com.
Orgenesis Inc., a service and research company, focus on the development and manufacture of cell therapy for advanced medicinal products in the field of regenerative medicine industry. The company was founded in 2008 and is based in Germantown, Maryland.
Orgenesis (ORGS) has collaborated with Educell Ltd., a European cell therapy company.Under the agreement, the parties plan to conduct one or more collaborative cell-based research projects aligned with local medical centers. The first collaboration will focus on the clinical development of CAR-T and whole cell-based vaccine platform for use in...
GERMANTOWN, Md., July 14, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs), today announces that it has entered into a Collaboration Agreement with Educell Ltd., a premier European cell therapy company. Under the agreement, the parties plan to conduct one or more collaborative cell-based research projects aligned with local medical centers.The companies will leverage the Orgenesis Cell and Gene Therapy (CGT) Biotech Platform which includes point of care (POCare) Networks, POCare Therapeutics and a POCare Technologies suite of proprietary and in-licensed technologies that have been engineered to create custom...
Annual Russell indexes reconstitution captures the 4,000 largest US stocks, ranking them by total market capitalization. Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes.